RevImmune
Blood & Organ Banks · Maryland, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
7513 Connelley Dr Ste I, Hanover, Maryla...Phone Number
(240) 497-8175Website
www.revimmune.comRevenue
<$5 MillionIndustry
ZI Rank: 2
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
2
1
2
1
2
About RevImmune
RevImmune specializes in T-Cell Technology & Development, focusing on enhancing immunotherapies. Their key product, IL-7, offers global T-cell support to improve treatment outcomes. The company operates primarily in the United States and Europe, targeting clients in the healthcare and biotechnology sectors. RevImmune is committed to advancing clinical development in the field of immunotherapy.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is RevImmune your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when RevImmune launches new products
Earning: See what the market has to say on RevImmune recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check out if RevImmune is spiking on competitors!
Click to see if RevImmune had a recent Job posting/layoffs
RevImmune, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at RevImmune
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once RevImmune has new funding data
Check if RevImmune has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined RevImmune as Masked Content
Find 2 more new buyers
Compare Similar Companies to RevImmune
Compare insights from companies similar to RevImmune, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
RevImmune
<$5M
1-10
Private
-
2014
N/A
Company Profile Activity
Activity Insights
RevImmune is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
RevImmune is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about RevImmune.
RevImmune Tech Stack
A closer look at the technologies used by RevImmune
RevImmune News & Media
RevImmune Announces Phase II Trial of the T-Cell Growth Factor CYT107 for COVID-19
Under Way in Europe Since May, In Preparation in the U.S. Designated As An Urgent Public Health National Priority In U.K. BETHESDA, Md., June 29, 2020 /PRNewswire/ -- RevImmune, a privately held biotechnology company developing CYT107 immune therapy for infectious diseases and cancer,...
Read more news
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding RevImmune
Sign Up For FreeTo access detailed company insights
RevImmune specializes in T-Cell Technology & Development, focusing on enhancing immunotherapies. Their key product, IL-7, offers global T-cell support to improve treatment outcomes. The company operates primarily in the United States and Europe, targeting clients in the healthcare and biotechnology sectors. RevImmune is committed to advancing clini... Read More
